TABLE 1.
Substratea | Vmax (μmol/min/mg) | Km (mM) | kcat/Km (min−1/mM) | Ki (mM) |
---|---|---|---|---|
3-N-Morpholinopropanesulfonic acid (MOPS) (0–20 mM) | 1.80 ± 0.06 | 0.24 ± 0.02 | 670.9 | 34.3 ± 5.8b |
N-Phenyltaurine (0–3 mM) | 0.81 ± 0.03 | 0.12 ± 0.01 | 606.4 | 1.5 ± 0.1b |
2-Hydroxyethanesulfonate (isethionate) (0–20 mM) | 1.26 ± 0.05 | 0.27 ± 0.05 | 418.4 | 20.3 ± 2.5b |
3-Morpholino-2-hydroxypropanesulfonic acid (MOPSO) (0–20 mM) | 1.51 ± 0.03 | 0.33 ± 0.02 | 411.2 | 28.4 ± 2.4b |
Taurocholate (0–10 mM) | 0.99 ± 0.05 | 0.42 ± 0.05 | 210.7 | 8.2 ± 1.1b |
2-(4-Morpholino)ethanesulfonic acid (MES) (0–20 mM) | 1.48 ± 0.05 | 1.94 ± 0.14 | 68.4 | 45.2 ± 6.6b |
2-(Cyclohexylamino)ethanesulfonic acid (CHES) (0–20 mM) | 0.56 ± 0.02 | 2.57 ± 0.34 | 19.6 | —c |
N-(Tris[hydroxymethyl]methyl)-2-amino-ethanesulfonic acid (TES) (0–15 mM) | 0.75 ± 0.01 | 3.60 ± 0.12 | 18.7 | —c |
N-[2-Hydroxyethyl] piperazine-N′-[2-hydroxy-propanesulfonic acid] (HEPPSO) (0–20 mM) | 1.01 ± 0.08 | 5.04 ± 1.07 | 18.0 | —c |
N-(Tris(hydroxymethyl)methyl)-3-aminopropane sulfonic acid (TAPS) (0–20 mM) | 1.61 ± 0.06 | 10.38 ± .80 | 13.9 | —c |
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (0–20 mM) | 0.82 ± 0.02 | 16.62 ± 0.80 | 4.4 | —c |
2-Aminoethanesulfonic acid (taurine) (0–20 mM) | 0.46 ± 0.04 | 10.37 ± 1.82 | 4.0 | —c |
The concentrations of substrates examined are shown in parentheses.
Data for these substrates were fit to the equation given in the text.
No inhibition was detected. Kinetic parameters were fit to the Michaelis-Menten equation.